Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119180773 | 11918077 | 3 | F | 20151208 | 20160802 | 20160114 | 20160810 | EXP | JP-009507513-1601JPN003645 | MERCK | 81.00 | YR | F | Y | 45.00000 | KG | 20160810 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119180773 | 11918077 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | 200 MG, BID | 17200 | MG | 20903 | 200 | MG | CAPSULE | BID | ||||
| 119180773 | 11918077 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, DAILY (DEVIDED DOSE FREQUENCY UNKNOWN) | 17200 | MG | 0 | 400 | MG | TABLET | QD | ||||
| 119180773 | 11918077 | 3 | C | PROHEPARUM | CHOLINE BITARTRATECYSTEINEINOSITOLMAMMAL LIVER | 1 | Oral | 2 DOSAGE FORM (DF), TID | U | 0 | 2 | DF | TABLET | TID | |||||
| 119180773 | 11918077 | 4 | C | URSODIOL. | URSODIOL | 1 | Oral | 300 MG, TID | U | 0 | 300 | MG | TABLET | TID | |||||
| 119180773 | 11918077 | 5 | C | HUSTAZOL (cloperastine fendizoate) | 2 | Unknown | DAILY DOSAGE UNKNOWN | U | 0 | ||||||||||
| 119180773 | 11918077 | 6 | C | BISOLVON | BROMHEXINE HYDROCHLORIDE | 1 | Unknown | DAILY DOSAGE UNKNOWN | U | 0 | |||||||||
| 119180773 | 11918077 | 7 | C | DEPAS | ETIZOLAM | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | TABLET | ||||||||
| 119180773 | 11918077 | 8 | C | ADALAT | NIFEDIPINE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID | |||||
| 119180773 | 11918077 | 9 | C | NU-LOTAN | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | TABLET | BID | |||||
| 119180773 | 11918077 | 10 | C | RANITIDINE HYDROCHLORIDE. | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, BID | U | 0 | 150 | MG | TABLET | BID | |||||
| 119180773 | 11918077 | 11 | C | GANATON | ITOPRIDE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | TABLET | BID | |||||
| 119180773 | 11918077 | 12 | C | SOLANAX | ALPRAZOLAM | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | TABLET | ||||||||
| 119180773 | 11918077 | 13 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119180773 | 11918077 | HO |
| 119180773 | 11918077 | DE |
| 119180773 | 11918077 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119180773 | 11918077 | Bradycardia | |
| 119180773 | 11918077 | Brain death | |
| 119180773 | 11918077 | Cardio-respiratory arrest | |
| 119180773 | 11918077 | Electrocardiogram QT prolonged | |
| 119180773 | 11918077 | General physical health deterioration | |
| 119180773 | 11918077 | Hypoxic-ischaemic encephalopathy | |
| 119180773 | 11918077 | Pneumonia | |
| 119180773 | 11918077 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119180773 | 11918077 | 1 | 20151027 | 20151208 | 0 | |
| 119180773 | 11918077 | 2 | 20151027 | 20151208 | 0 |